Statin safety: myths and reality
More frequent statin prescription, to achieve lower target low-density lipoprotein levels, as well as statin dose increase, is associated with inevitable raise in adverse event rates. The article compares statin benefits and the risk of adverse liver, muscle, brain, and kidney effects.
Main Authors: | Zh. D. Kobalava, S. V. Villevalde, E. K. Shavarova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2007-04-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1212 |
Similar Items
-
Statin treatment: myths and reality
by: L. A. Malay, et al.
Published: (2008-06-01) -
Estatinas, uso racional en el tratamiento de la dislipoproteinemia Statins related to a rational use in treatment of dyslipoproteinemia
by: José Illnait Ferrer
Published: (2009-09-01) -
Management of statin intolerance
by: Soma B Raju, et al.
Published: (2013-01-01) -
Statins associated diabetes: state of the problem in 2018
by: Zh. D. Kobalava, et al.
Published: (2018-09-01) -
Developmentand Validation of a Questionnaire about Patient Knowledge of Adverse Effects of Statins
by: Opančina Valentina, et al.
Published: (2016-12-01)